The most effective natural Frozen Shoulder treatment
Click on a box to see what we consider
the most effective natural Frozen Shoulder treatment for you

WOMEN 39
AND UNDER		 MEN 39
AND UNDER		 WOMEN 40
AND UP		 MEN 40
AND UP
click here...click here...click here...click here...

What is frozen shoulder (adhesive capsulitis)?

Commonly known as frozen shoulder, adhesive capsulitis is characterized by the shrinking of the shoulder joint capsule. Movement of the shoulder in all directions is restricted and painful. If you are a woman aged 40 to 60, you are most likely to be affected by this condition.

The cause of frozen shoulder is not known; however, inflammation of the periarticular tissue (tissue surrounding a joint) plays an important role. Conventional treatment has only proven effective in a few cases and it is very likely that a lack of essential anti-inflammatory substances in the body is a triggering cause. These anti-inflammatory natural nutrients (see below) in combination with physical therapy and medical acupuncture provide an effective treatment.

Which natural ingredients can have an effect on frozen shoulder?

Chondroitin sulfate, glucosamine sulfate, ginger root extract, methylsulfonylmethane (MSM), grape seed extract, alpha-lipoic acid, fish oils (EPA/DHA), quercetin, vitamins A, B2, B3, C, D3, E and folic acid, magnesium, zinc, selenium, manganese, boron, copper, molybdenum and many more.

What effects do these ingredients have?

  • Most effective analgesic for moderate to severe pain.
  • Long-term analgesic effect.
  • More effective than NSAIDs.
  • Often reestablish normal movement within weeks/months.
  • Generate more energy.
  • Improve quality of life.

For the reader with a deeper interest:

How do these ingredients work?

  • Treat and prevent vitamin and mineral deficiencies.
  • Inhibit cyclooxygenase-2 (COX-2).
  • Inhibit the breakdown of collagenase phospholipases.
  • Inhibit TNF-a and interleukin-1B.
  • Inhibit the production of leukotriene B4 and prostaglandin E2.
  • Stimulate the production of proteoglycans and glycosaminoglycans.
  • Normalize the viscosity of synovial fluid.
  • Stimulate ATP synthesis of the mitochondrion.
  • Antioxidant effect.
  • Inhibit the oxidation of fatty substances such as LDL cholesterol.
  • No harmful side effects.

The information above is based on more than 1,000,000 articles published in scientific journals and which are available at MEDLINE, the world’s largest medical database. Below you will find a few of them listed:

References

  1. Adam O, Beringer C, Kless T, et al. Anti-inflammatory effects of a low arachidonic acid diet and fish oil in patients with rheumatoid arthritis. Rheumatol Int. 2003;23:27–36. ***
  2. Adler AJ, Holub BJ. Effect of garlic and fish-oil supplementation on serum lipid and lipoprotein concentrations in hypercholesterolemic men. Am J Clin Nutr 1997; 65:445–50.
  3. Agarwal R, et al. Cancer Chemoprevention by Polyphenols in Green Tea and Artichoke. Adv Exp Med Biol. 1996;401:35-50.
  4. Agren JJ, Hanninen O, Julkunen A, et al. Fish diet, fish oil and docosahexaenoic acid rich oil lower fasting and postprandial plasma lipid levels. Eur J Clin Nutr. 1996;50:765-771.
  5. Alexander JW. Immunonutrition: the role of omega-3 fatty acids.Nutr 1998;14:627–33.
  6. Ali M, Afzal M, Gubler CJ, Burka JF. A potent thromboxane formation inhibitor in green tea leaves.Prostaglandins Leukot Essent Fatty Acids 40:281-283; 1990.
  7. Ali M, et al. A Potent Inhibitor of Thrombin Stimulated Platelet Thromboxane Formation from Unprocessed Tea. Prostaglandins Leukot Med. Apr1987;27(1):9-13.
  8. Almallah YZ, El-Tahir A, Heys SD, et al. Distal procto-colitis and n-3 polyunsaturated fatty acids: the mechanism(s) of natural cytotoxicity inhibition. Eur J Clin Invest. 2000;30:58–65.
  9. American Herbal Products Association. Use of Marker Compounds in Manufacturing and Labeling Botanically Derived Dietary Supplements. Silver Spring, MD: American Herbal Products Association; 2001.
  10. Angerer P, Stork S, Kothny W, et al. Effect of marine omega-3 fatty acids on peripheral atherosclerosis in patients with coronary artery disease—a randomised 2 year intervention trial [abstract]. Eur Heart J. 2001;22(suppl):162.
  11. Angerer P, Stork S, Kothny W, et al. Effect of marine omega-3 fatty acids on peripheral atherosclerosis in patients with coronary artery disease—a randomised 2 year intervention trial [abstract]. Eur Heart J. 2001;22(suppl):162.
  12. Anon. Promensil. Scientific brochure. North Ryde (Australia): Novogen; 1999.
  13. Anthony MS, et al. Effects of soy isoflavones on atherosclerosis: potential mechanisms. Am J Clin Nutr. Dec1998;68(6 Suppl):1390S-1393S.
  14. Appel LJ, Miller ER III, Seidler AJ, et al. Does supplementation of diet with 'fish oil' reduce blood pressure? A meta-analysis of controlled clinical trials. Arch Intern Med. 1993;153:1429–1438.
  15. Arm J. The effects of dietary supplementation with fish oil on asthmatic responses to antigen. J Allergy Clin Immunol. 1988;81:183.
  16. Arm JP, Thien FC, Lee TH. Leukotrienes, fish-oil, and asthma. Allergy Proc. 1994;15:129–134.
  17. Ascherio A, Rimm EB, Stampfer MJ, et al. Dietary intake of marine n-3 fatty acids, fish intake, and the risk of coronary disease among men. N Engl J Med. 1995;332:977–982.
  18. Ascherio A, Rimm EB, Stampfer MJ, et al. Dietary intake of marine n-3 fatty acids, fish intake, and the risk of coronary disease among men. N Engl J Med. 1995;332:977–982.
  19. Aslan A, Triadafilopoulos G. Fish oil fatty acid supplementation in active ulcerative colitis: a double-blind, placebo-controlled, crossover study. Am J Gastroenterol. 1992;87:432–437.
  20. Auer J, et al. Homocysteine and cardiovascular risk. Wien Med Wochenschr. 2001;151(1-2):25-8.
  21. Baber R, et al. The effect of an isoflavone dietary supplement (P-081) on serum lipids, forearm bone density and endometrial thickness in post-menopausal women. NYC: Abstract from NAMS 10th Annual Meeting; Sep1999.*
  22. Baber RJ, Templeman C, Morton T, et al. Randomized placebo-controlled trial of an isoflavone supplement and menopausal symptoms in women. Climacteric. 1999;2:85–92. *
  23. Bailey L. New standard for dietary folate intake in pregnant women. Am J Clin Nutr 2000;71(Suppl):1304S–7S [review].
  24. Barber MD. Cancer cachexia and its treatment with fish-oil-enriched nutritional supplementation. Nutrition. 2001;17:751–755.
  25. Bassey EJ, Littlewood JJ, Rothwell MC, et al. Lack of effect of supplementation with essential fatty acids on bone mineral density in healthy pre- and postmenopausal women: two randomized controlled trials of EfacalW v. calcium alone. Br J Nutr. 2000;83:629–635.
  26. Bates D. Dietary lipids and multiple sclerosis. Ups J Med Sci Suppl. 1990;48:173–187.
  27. Beaulieu AJ, Gohh RY, Han H, et al. Enhanced reduction of fasting total homocysteine levels with supraphysiological versus standard multivitamin dose folic acid supplementation in renal transplant recipients. Arterioscler Thromb Vasc Biol 1999;19:2918–21.
  28. Beck V, Unterrieder E, Krenn L, Kubelka W, Jungbauer A. Comparison of hormonal activity (estrogen, androgen and progestin) of standardized plant extracts for large scale use in hormone replacement therapy. J Steroid Biochem Mol Biol. Feb2003;84(2-3):259-68.
  29. Behan PO, Behan WM, Horrobin D. Effect of high doses of essential fatty acids on the postviral fatigue syndrome. Acta Neurol Scand. 1990;82:209–216.
  30. Belluzzi A, Brignola C, Campieri M, et al. Effect of an enteric-coated fish-oil preparation on relapses in Crohn's disease. N Engl J Med. 1996;334:1557–1560.**
  31. Belluzzi A, Brignola C, Campieri M, et al. Effects of new fish oil derivative on fatty acid phospholipid-membrane pattern in a group of Crohn’s disease patients. Dig Dis Sci 1994;39:2589–94.
  32. Bendich A, Deckelbaum R, eds. Prevention Nutrition: The Comprehensive Guide for Health Professionals. Totowa, NJ: Humana Press; 1997.
  33. Benito E, Stiggelbout A, Bosch FX, et al. Nutritional factors in colorectal cancer risk: a case-control study in Majorca. Int J Cancer 1991;49:161–7.
  34. Benzie IF, Szeto YT, Strain JJ, Tomlinson B. Consumption of green tea causes rapid increase in plasma antioxidant power in humans. Nutr Cancer 1999;34:83–7.
  35. Billman GE, Hallaq H, Leaf A. Prevention of ischemia-induced ventricular fibrillation by omega 3 fatty acids. Proc Natl Acad Sci U S A. 1994;91:4427–4430.
  36. Bittiner SB, Cartwright I, Tucker WFG, et al. A double-blind, randomised, placebo-controlled trial of fish oil in psoriasis. Lancet. 1988;1:378–380.
  37. Blakesmith SJ, Lyons-Wall PM, George C, et al. Effects of supplementation with purified red clover (Trifolium pratense) isoflavones on plasma lipids and insulin resistance in healthy premenopausal women. Br J Nutr. 2003;89:467–475.
  38. Blommers J, De Lange-De Klerk ES, Kuik DJ, et al. Evening primrose oil and fish oil for severe chronic mastalgia: A randomized, double-blind, controlled trial. Am J Obstet Gynecol. 2002;187:1389–1394.
  39. Blumenthal M, Busse WR, Goldberg A, et al. (eds). The Complete Commission E Monographs: Therapeutic Guide to Herbal Medicines. Boston, MA: Integrative Medicine Communications, 1998, 90.
  40. Blumenthal M., et al, eds. S. Klein and R. S. Rister, translators. German Commission E Monographs: Therapeutic Monographs on Medicinal Plants for Human Use. Austin, Texas: American Botanical Council. In press, 1998.
  41. Bostom AG, Gohh RY, Beaulieu AJ, et al. Treatment of hyperhomocysteinemia in renal transplant recipients. A randomized, placebo-controlled trial. Ann Intern Med 1997;127:1089–92.
  42. Bostom AG, Silbershatz H, Rosenberg IH, et al. Non-fasting plasma total homocysteine levels and all-cause and cardiovascular disease mortality in elderly Framingham men and women. Arch Intern Med 1999;159:1077–80.
  43. Braden LM, Carroll KK. Dietary polyunsaturated fat in relation to mammary carcinogenesis in rats. Lipids 1986;21(4):285.
  44. Bradley PR, ed. British Herbal Compendium, vol 1. Bournemouth, Dorset, UK: British Herbal Medicine Association, 1992, 34–6.
  45. Bradley, P. R. British Herbal Compendium Vol. 1. A Handbook of Scientific Information on Widely Used Plant Drugs.. Dorset, U.K. British Herbal Medicine Association, 1992.
  46. Brattstrom LE, et al. Folic Acid – An Innocuous Means to Reduce plasma Homocysteine. Scand J Clin Lab Invest. May1988;48(3):215-21.
  47. Brattstrom LE, et al. Folic Acid Responsive Postmenopausal Homocysteinemia. Metabolism. Nov1985;34(11):1073-77.
  48. Bronstrup A, Hages M, Prniz-Langenohl R, Pietrzik K. Effects of folic acid and combinations of folic acid and vitamin B12 on plasma homocysteine concentrations in healthy, young women. Am J Clin Nutr. 1998;68:1104-1110.
  49. Brouwer IA, van Dusseldorp M, Thomas CM, Duran M, Hautvast JG, Eskes TK, et al. Low-dose folic acid supplementation decreases plasma homocysteine concentrations: a randomized trial. Am J Clin Nutr. Jan1999;69(1):99-104.
  50. Brown, D. Herbal Prescriptions for Better Health. Rocklin, Calif. Prima Publishing, 1995
  51. Bruera E, Strasser F, Palmer JL, et al. Effect of fish oil on appetite and other symptoms in patients with advanced cancer and anorexia/cachexia: a double-blind, placebo-controlled study. J Clin Oncol. 2003;21:129–134.
  52. Bucher HC, Hengstler P, Schindler C, et al. N-3 polyunsaturated fatty acids in coronary heart disease: a meta-analysis of randomized controlled trials. Am J Med. 2002;112:298-304.***
  53. Buck AC, Jenkins A, Lingam K, et al. The treatment of idiopathic recurrent urolithiasis with fish oil (EPA) and evening primrose oil (GLA)—a double blind study. J Urol. 1993;149:253A.
  54. Buckley DI, et al. Dietary Micronutrients and Cervical Dysplasia in Southwestern American Indian Women. Nutr Cancer. 1992;17(2):179-85.
  55. Bunout D, Petermann M, Hirsch S, et al. Low serum folate but normal homocysteine levels in patients with atherosclerotic vascular disease and matched healthy controls. Nutrition 2000;16:434–8.
  56. Burns CP, Halabi S, Clamon GH, et al. Phase I clinical study of fish oil fatty acid capsules for patients with cancer cachexia: cancer and leukemia group B study 9473. Clin Cancer Res 1999;5:3942–7.
  57. Burr ML, Fehily AM, Gilbert JF, et al. Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART). Lancet. 1989;2:757–761.
  58. Butterworth CE Jr, Tamura T. Folic acid safety and toxicity: a brief review. Am J Clin Nutr 1989;50:353–8.
  59. Calvaresi E, Bryan J. B vitamins, cognition, and aging: a review. J Gerontol B Psychol Sci Soc Sci. Nov2001;56(6):P327-39.
  60. Cancers, Nutrition and Food. Washington, DC: World Cancer Research Fund/American Institute for Cancer Research; 1997.
  61. Cassady JM, Zennie TM, Chae YH, Ferin MA, Portuondo NE, Baird WM. Use of a mammalian cell culture benzo(a)pyrene metabolism assay for the detection of potential anticarcinogens from natural products: inhibition of metabolism by biochanin A, an isoflavone from Trifolium pratense L. Cancer Res. 1988 Nov 15;48(22):6257-61.
  62. Castleman M. The Healing Herbs. Emmaus, PA: Rodale Press, 1991, 75–8.
  63. Cheng TO. Antioxidants in Chinese Green Tea. J Am Coll Cardiol. Apr1998;31(5):1214.
  64. Childs MT, King IB, Knopp RH. Divergent lipoprotein responses to fish oils with various ratios of eicosapentaenoic acid and docosahexaenoic acid. Am J Clin Nutr. 1990;52:632-639.
  65. Chosa H, Toda M, Okubo S, et al. [Antimicrobial and microbicidal activities of tea and catechins against Mycoplasma]. Kansenshogaku Zasshi 66:606-611; 1992.
  66. Clark WF, Parbtani A, Naylor CD, et al. Fish oil in lupus nephritis: clinical findings and methodological implications. Kidney Int. 1993;44:75–86.
  67. Clark WF, Parbtani A. Omega-3 fatty acid supplementation in clinical and experimental lupus nephritis. Am J Kidney Dis. 1994;23:644–647.
  68. Cleland L, James M, Proudman S. The role of fish oils in the treatment of rheumatoid arthritis. Drugs. 2003;63:845–853.
  69. Cobiac L, Clifton PM, Abbey M, et al. Lipid, lipoprotein, and hemostatic effects of fish vs fish-oil n–3 fatty acids in mildly hyperlipidemic males. Am J Clin Nutr. 1991;53:1210–1216.
  70. Conquer JA, Martin JB, Tummon I, et al. Effect of DHA supplementation on DHA status and sperm motility in asthenozoospermic males. Lipids. 2000;35:149–154.
  71. Cunnane SC, Ho SY, Dore-Duffy P, et al. Essential fatty acid and lipid profiles in plasma and erythrocytes in patients with multiple sclerosis. Am J Clin Nutr. 1989;50:801–806.
  72. Curb JD, Reed DM. Fish consumption and mortality from coronary heart disease [letter]. N Engl J Med. 1985;313:821–822.
  73. Czeizel AE, Timar L, Sarkozi A. Dose-dependent effect of folic acid on the prevention of orofacial clefts. Pediatrics 1999;104:e66.
  74. Czeizel AE, Toth M, Rockenbauer M. Population-based case control study of folic acid supplementation during pregnancy. Teratology 1996;53:345–51.
  75. Czeizel AE, Toth M, Rockenbauer M. Population-based case control study of folic acid supplementation during pregnancy. Teratology 1996;53:345–51.
  76. Daly LE, Kirke PN, Molloy A, et al. Folate levels and neural tube defects. JAMA 1995;274:1698–702.
  77. Davidson MH, Maki KC, Kalkowski J, et al. Effects of docosahexaenoic acid on serum lipoproteins in patients with combined hyperlipidemia: a randomized, double-blind, placebo-controlled trial. J Am Coll Nutr. 1997;16:236-243.
  78. de Lorgeril M, Renaud S, Mamelle N, et al. Mediterranean alpha-linolenic acid-rich diet in secondary prevention of coronary heart disease. Lancet. 1994;343:1454–1459.
  79. de Lorgeril M, Renaud S, Mamelle N, et al. Mediterranean alpha-linolenic acid-rich diet in secondary prevention of coronary heart disease. Lancet. 1994;343:1454–1459.
  80. Deodato B, et al. Cardioprotection by the phytoestrogen genistein in experimental myocardial ischaemia-reperfusion injury. Br J Pharmacol. Dec1999;128(8):1683-90.
  81. Deutch B, Jorgensen EB, Hansen JC. Menstrual discomfort in Danish women reduced by dietary supplements of omega-3 PUFA and B12 (fish oil or seal oil capsules). Nutr Res. 2000;20:621–631.***
  82. Dierkes J, Kroesen M, Pietrzik K. Folic acid and vitamin B6 supplementation and plasma homocysteine concentrations in healthy young women. Int J Vitam Nutr Res 1998;68:98–103.
  83. Dierkes J, Westphal S, Kunstmann S, Banditt P, Lossner A, Luley C. Vitamin supplementation can markedly reduce the homocysteine elevation induced by fenofibrate. Atherosclerosis. Sep2001;158(1):161-4.
  84. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico. Lancet. 1999;354:447–455.
  85. DiGiacomo RA, Kremer JM, Shah DM. Fish-oil dietary supplementation in patients with Raynaud's phenomenon: a double-blind, controlled, prospective study. Am J Med. 1989;86:158–164.
  86. Dixon-Shanies D, Shaikh N. Growth Inhibition of Human Breast Cancer Cells by Herbs and Phytoestrogens. Oncol Rep. Nov1999;6(6):1383-7.
  87. Dolecek TA, Granditis G. Dietary polyunsaturated fatty acids and mortality in the Multiple Risk Factor Intervention Trial (MRFIT). World Rev Nutr Diet. 1991;66:205–216.
  88. Dolecek TA, Granditis G. Dietary polyunsaturated fatty acids and mortality in the Multiple Risk Factor Intervention Trial (MRFIT). World Rev Nutr Diet. 1991;66:205–216.
  89. Donadio JV Jr, Bergstrahl EJ, Offord KP, et al. A controlled trial of fish oil in IgA nephropathy. N Engl J Med 1994;331:1194–9.
  90. Donadio JV Jr, Grande JP, Bergstralh EJ, et al. The long-term outcome of patients with IgA nephropathy treated with fish oil in a controlled trial. J Am Soc Nephrol. 1999;10:1772–1777.
  91. Drug Facts and Comparisons 1999. Facts and Comparisons; 1998.
  92. Dry J, Vincent D. Effect of a fish oil diet on asthma: Results of a one-year double-blind study. Int Arch Allergy Immunol. 1991;95:156–157.
  93. Düker EM, Kopanski L, Jarry H, Wuttke W. Effects of extracts from Cimicifuga racemosa on gonadotropin release in menopausal women and ovariectomized rats. Planta Medica 1991;57:420–4.
  94. Dulloo AG, Sevdoux J, Girardier L, et al. Green Tea and Thermogenesis: Interactions Between Catechin-polyphenols, Caffeine and Sympathetic Activity. Int J Obes Relat Metab Disord. Feb2000;24(2):252-8.
  95. Dunstan DW, Burke V, Mori TA, et al. The independent and combined effects of aerobic exercise and dietary fish intake on serum lipids and glycemic control in NIDDM. Diabetes Care 1997; 20:913–21.
  96. Durrington PN, Bhatnagar D, Mackness MI, et al. An omega-3 polyunsaturated fatty acid concentrate administered for one year decreased triglycerides in simvastatin treated patients with coronary heart disease and persisting hypertriglyceridaemia. Heart. 2001;85:544–548.
  97. Dyerberg J. N-3 fatty acids and coronary artery disease: potentials and problems. Omega-3, Lipoproteins, and Atherosclerosis. 1996;27:251–258.
  98. Ebly EM, Schaefer JP, Campbell NR, Hogan DB. Folate status, vascular disease and cognition in elderly Canadians. Age Ageing. 1998;27:485-491.
  99. Edwards R, Peet M, Shay J, Horrobin D. Omega-3 polyunsaturated fatty acid levels in the diet and in red blood cell membranes of depressed patients. J Affect Disord 1998;48:149–55.
  100.  Einer-Jensen N, Zhao J, Andersen KP, Kristoffersen K. Cimicifuga and Melbrosia lack estrogenic effects in mice and rats. Maturitas 1996;25:149–53.
  101.  Emsley R, Myburgh C, Oosthuizen P, et al. Randomized, placebo-controlled study of ethyl-eicosapentaenoic Acid as supplemental treatment in schizophrenia. Am J Psychiatry. 2002;159:1596-1598.
  102.  Evans BA, et al. Inhibition of 5 alpha-reductase in genital skin fibroblasts and prostate tissue by dietary lignans and isoflavonoids. J Endocrinol. Nov1995;147(2):295-302.
  103.  Fenton WS, Dickerson F, Boronow J, et al. A placebo-controlled trial of omega-3 fatty acid (ethyl eicosapentaenoic acid) supplementation for residual symptoms and cognitive impairment in schizophrenia. Am J Psychiatry 2001;158:2071–4.
  104.  Food standards: amendment of standards of identity for enriched grain products to require addition of folic acid. Fed Regist 1996;61:8781–97.
  105.  Foster S. Herbs for Your Health. Loveland, CO: Interweave Press, 1996, 12–3.
  106.  Freudenheim JL, Graham S, Marshall JR, et al. Folate intake and carcinogenesis of the colon and rectum. Int J Epidemiol 1991;20:368–74.
  107.  Fujiki H, Yoshizawa S, Horiuchi T, et al. Anticarcinogenic effects of (-)-epigallocatechin gallate. Prev Med 21:503-509; 1992.
  108.  Galanis DJ, Kolonel LN, Lee J, Nomura A. Intakes of selected foods and beverages and the incidence of gastric cancer among the Japanese residents of Hawaii: a prospective study. Int J Epidemiol 1998;27:173–80.
  109.  Gallai V, Sarchielli P, Trequattrini A, et al. Cytokine secretion and eicosanoid production in the peripheral blood mononuclear cells of MS patients undergoing dietary supplementation with n-3 polyunsaturated fatty acids. J Neuroimmunol. 1995;56:143–153.
  110.  Gao YT, McLaughlin JK, Blot WJ, et al. Reduced risk of esophageal cancer associated with green tea consumption. J Natl Cancer Inst 86:855-858; 1994.
  111.  Geleijnse JM, Giltay EJ, Grobbee DE, et al. Blood pressure response to fish oil supplementation: metaregression analysis of randomized trials. J Hypertens. 2002;20:1493-1499.
  112.  Gerbi A, Maixent JM, Ansaldi JL, et al. Fish oil supplementation prevents diabetes-induced nerve conduction velocity and neuroanatomical changes in rats. J Nutr. 1999;129:207–213.
  113.  Giles WH, Kittner SJ, Croft JB, Anda RF, Casper ML, Ford ES. Serum folate and risk for coronary heart disease: Results from a cohort of US adults. Ann Epidemiol. 1998;8:490-496.
  114.  Giovannucci E, Stampfer MJ, Colditz GA, et al. Multivitamin use, folate and colon cancer in women in the Nurse’s Health Study. Ann Intern Med 1998;129:517–24.
  115.  Glencross RG, Festenstein GN, King HG. Separation and determination of isoflavones in the protein concentrate from red clover leaves. J Sci Food Agric. 1972 Mar;23(3):371-6.
  116.  Glueck CJ, McCarren T, Hitzemann R, et al. Amelioration of severe migraine with omega-3 fatty acids: a double-blind, placebo-controlled clinical trial [abstract]. Am J Clin Nutr. 1986;43:710.
  117.  Godfrey PS, et al. Enhancement of Recovery from Psychiatric Illness by Methylfolate. Lancet. Aug1990;336(8712):392-95.
  118.  Goldberg P, Fleming MC, Picard EH. Multiple sclerosis: decreased relapse rate through dietary supplementation with calcium, magnesium and vitamin D. Med Hypotheses. 1986;21:193–200.
  119.  Gonzalez MJ. Fish oil, lipid peroxidation and mammary tumor growth. J Am Coll Nutr 1995;14:325.
  120.  Goto K, Kanaya S, Ishigami T, Hara Y. The effects of tea catechins on fecal conditions of elderly residents in a long-term care facility. J Nutr Sci Vitaminol 1999;45:135–41.
  121.  Goto K, Kanaya S, Nishikawa T, et al. The influence of tea catechins on fecal flora of elderly residents in long-term care facilities. Ann Long-Term Care 1998;6:43–8.
  122.  Graham HN. Green tea composition, consumption, and polyphenol chemistry. Prev Med 1992;21:334–50.
  123.  Green tea. Altern Med Rev. Aug2000;5(4):372-5.
  124.  Greenfield SM, Green AT, Teare JP, et al. A randomized controlled study of evening primrose oil and fish oil in ulcerative colitis. Aliment Pharmacol Ther. 1993;7:159–166.
  125.  Grinberg LN, et al. Protective Effects of Tea Polyphenols against Oxidative Damage to Red Blood Cells. Biochem Pharmacol. Nov1997;54(9):973-78.
  126.  Gruenwald J. Standardized black cohosh (Cimicifuga) extract clinical monograph. Quart Rev Nat Med 1998;Summer:117–25.
  127.  Grunert E, Woelke G. Isoflavones in some white and red clover varieties and their oestrogenic effect in juvenile mice. Dtsch Tierarztl Wochenschr. 1967 Sep 1;74(17):431-
  128.  Guallar E, Hennekens CH, Sacks FM, et al. A prospective study of plasma fish oil levels and incidence of myocardial infarction in U.S. male physicians. J Am Coll Cardiol. 1995;25:387–394.
  129.  Hale GE, et al. A double-blind randomized study on the effects of red clover isoflavones on the endometrium. Menopause 2001;8:338-46.****
  130.  Halsted CH, Ghandi G, Tamura T. Sulfasalazine inhibits the absorption of folates in ulcerative colitis. N Engl J Med. 1981;305:1513–1517.
  131.  Hamilton-Miller JM. Antimicrobial properties of tea (Camellia sinensis L.). Antimicro Agents Chemother 1995;39:2375–7.
  132.  Hardman WE, Moyer MP, Cameron IL. Consumption of an omega-3 fatty acids product, INCELL AAFA, reduced side-effects of CPT-11 (irinotecan) in mice. Br J Cancer. 2002;86:983-988.
  133.  Harel Z, Biro FM, Kottenhahn RK, et al. Supplementation with omega-3 polyunsaturated fatty acids in the management of dysmenorrhea in adolescents. Am J Obstet Gynecol. 1996;174:1335–1338.
  134.  Harel Z, Gascon G, Riggs S, et al. Supplementation with omega-3 polyunsaturated fatty acids in the management of recurrent migraines in adolescents. J Adolesc Health. 2002;31:154-161.
  135.  Harnischfeger, G. and H. Stolze. Black Cohosh. Notabene Medici 1980, 10:446-50.
  136.  Harris WS, Zucker ML, Dujovne CA. Omega-3 fatty acids in type IV hyperlipidemia: fish oils vs methyl esters. Am J Clin Nutr 1987;45:858 [abstr].
  137.  Harris WS. Dietary fish oil and blood lipids. Curr Opin Lipidol. 1996;7:3–7.
  138.  Harris WS. N-3 fatty acids and lipoproteins: comparison of results from human and animal studies. Lipids. 1996;31:243–252.
  139.  Harris WS. N-3 fatty acids and serum lipoproteins: human studies. Am J Clin Nutr. 1997;65(5 suppl):S1645–S1654.
  140.  Hawthorne AB, Daneshmend TK, Hawkey CJ, et al. Treatment of ulcerative colitis with fish oil supplementation: a prospective 12-month randomised controlled trial. Gut. 1992;33:922–928.
  141.  Helland IB, Smith L, Saarem K, et al. Maternal supplementation with very-long-chain n-3 fatty acids during pregnancy and lactation augments children's IQ at 4 years of age. Pediatrics. 2003;111:E39–E44.
  142.  Hertog MG, et al. Antioxidant Flavonols and Ischemic Heart Disease in a Welsh Population of Men: The Caerphilly Study. Am J Clin Nutr. May1997;65(5):1489-94.
  143.  Hertog MG, et al. Dietary Antioxidant Flavonoids and Risk of Coronary Heart Disease: The Zutphen Elderly Study. Lancet. Oct1993;342(8878):1007-1011.
  144.  Hibbeln JR, Salem N Jr. Dietary polyunsaturated fatty acids and depression: when cholesterol does not satisfy. Am J Clin Nutr. 1995;62:1–9.
  145.  Hirose M, Hoshiya T, Akagi K, et al. Inhibition of mammary gland carcinogenesis by green tea catechins and other naturally occurring antioxidants in female Sprague-Dawley rats pretreated with 7,12 dimethylbenz[alpha]anthracene. Cancer Lett 83:149-156; 1994.
  146.  Hodgson JM, Puddey IB, Burke V, et al. Effects on Blood Pressure of Drinking Green and Black Tea. J Hypertens. Apr1999;17(4):457-63.’
  147.  Horiuchi Y, Toda M, Okubo S, et al. [Protective activity of tea and catechins against Bordetella pertussis]. Kansenshogaku Zasshi 66:599-605; 1992.
  148.  Houston DK, Johnson MA, Nozza RJ, et al. Age-related hearing loss, vitamin B-12, and folate in elderly women. Am J Clin Nutr 1999;69:564–71.
  149.  Howes JB, Sullivan D, Lai N, Nestel P, Pomeroy S, West L, Eden JA, Howes LG. The effects of dietary supplementation with isoflavones from red clover on the lipoprotein profiles of post menopausal women with mild to moderate hypercholesterolaemia. Atherosclerosis. 2000 Sep;152(1):143-7.
  150.  Hu G, et al. Inhibition of Oncogene Expression by Green Tea and (-)-Epigallocatechin Gallate in Mice. Nutr Cancer. 1995;24(2):203-09.
  151.  Imai K, Nakachi K. Cross sectional study of effects of drinking green tea on cardiovascular and liver diseases. BMJ 1995;310:693–6.
  152.  Imai K, Suga K, Nakachi K Department of Epidemiology, Saitama Cancer Center Research Institute, Japan. Cancer-preventive effects of drinking green tea among a Japanese population. Prev Med 1997 Nov-Dec;26(6):769-75
  153.  Ingram DM, Hickling C , West L, et al. A double-blind randomized controlled trial of isoflavones in the treatment of cyclical mastalgia. The Breast 2002;11:170-174.
  154.  Ishimi Y, et al. Selective effects of genistein, a soybean isoflavone, on B-lymphopoiesis and bone loss caused by estrogen deficiency. Endocrinology. Apr1999;140(4):1893-900.*
  155.  Iso H, Rexrode KM, Stampfer MJ, et al. Intake of fish and omega-3 fatty acids and risk of stroke in women. JAMA. 2001;285:304–312.
  156.  Jacobs MN, Santillo D, Johnston PA, et al. Organochlorine residues in fish oil dietary supplements: comparison with industrial grade oils. Chemosphere. 1998;37:1709-1721.
  157.  Jacobson JS, Troxel AB, Evans J, Klaus L, Vahdat L, Kinne D, et al. Randomized trial of black cohosh for the treatment of hot flashes among women with a history of breast cancer. J Clin Oncol. May2001;19(10):2739-45.
  158.  Jacques PF, Selhub J, Bostom AG, et al. The effect of folic acid fortification on plasma folate and total homocysteine concentrations. N Engl J Med 1999;340:1449–54.
  159.  James MJ, Cleland LG. Dietary n-3 fatty acids and therapy for rheumatoid arthritis. Semin Arthritis Rheum. 1997;27:85–97.
  160.  Jankun J, et al. Why Drinking Green Tea Could Prevent Cancer. Nature. Jun1997;387(6633):561.
  161.  Jarry H, et al. The Endocrine Effects of Constituents of Cimicifuga racemosa. . In Vitro Binding of Constituents to Estrogen Receptors. Planta Med. Aug1985;4:316-19.
  162.  Jarry H, Harnischfeger G, Düker E. Studies on endocrine effects of the contents of Cimicifuga racemosa. 2. In vitro binding of compounds to estrogen receptors. Planta Medica 1985;51:316–9.
  163.  Jarry, H. and G. Harnischfeger. Studies on the endocrine effects of the contents of Cimicifuga racemosa: 1. Influence on the serum concentration of pituitary hormones in Ovariectomized rats. Planta Medica. 1985, 51(1): 46-49.
  164.  Kabuto H, Yokoi I, Mori A. Monoamine metabolites, iron induced seizures, and the anticonvulsant effect of tannins. Neurochem Res 17:585-590; 1992.
  165.  Kadota S, Li JX, Litt Y, et al. Effects of cimicifugae rhizome on serum calcium and phosphate levels in low calcium dietary rats and on bone mineral density in ovariectomized rats. Phytomed 1996/7;3:379–85.
  166.  Kallela K, Heinonen K, Saloniemi H. Plant oestrogens; the cause of decreased fertility in cows. A case report. Nord Vet Med. 1984 Mar-Apr;36(3-4):124-9. & more.